Cargando…
Altered Surface Expression of Insulin-Degrading Enzyme on Monocytes and Lymphocytes from COVID-19 Patients Both at Diagnosis and after Hospital Discharge
Although the COVID-19 disease has developed into a worldwide pandemic, its pathophysiology remains to be fully understood. Insulin-degrading enzyme (IDE), a zinc-metalloprotease with a high affinity for insulin, has been found in the interactomes of multiple SARS-CoV-2 proteins. However, the relevan...
Autores principales: | González-Casimiro, Carlos M., Arribas-Rodríguez, Elisa, Fiz-López, Aida, Casas, Javier, Gutiérrez, Sara, Tellería, Pablo, Novoa, Cristina, Rojo-Rello, Silvia, Tamayo, Eduardo, Orduña, Antonio, Dueñas, Carlos, Bernardo, David, Perdomo, German |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9570012/ https://www.ncbi.nlm.nih.gov/pubmed/36232381 http://dx.doi.org/10.3390/ijms231911070 |
Ejemplares similares
-
Targeting Insulin-Degrading Enzyme in Insulin Clearance
por: Leissring, Malcolm A., et al.
Publicado: (2021) -
Metabolomics study of COVID-19 patients in four different clinical stages
por: Valdés, Alberto, et al.
Publicado: (2022) -
Growth Arrest-Specific Factor 6 (GAS6) Is Increased in COVID-19 Patients and Predicts Clinical Outcome
por: Morales, Albert, et al.
Publicado: (2021) -
Primary Cilia in Pancreatic β- and α-Cells: Time to Revisit the Role of Insulin-Degrading Enzyme
por: Pablos, Marta, et al.
Publicado: (2022) -
Evaluation of Cytokines as Robust Diagnostic Biomarkers for COVID-19 Detection
por: Tamayo-Velasco, Álvaro, et al.
Publicado: (2021)